These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12879950)

  • 1. Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy.
    Joh R; Hasegawa K; Tokushige K; Hashimoto E; Torii N; Yamashiro T; Enomoto N; Watanabe M; Hayashi N
    Intern Med; 2003 Jul; 42(7):581-6. PubMed ID: 12879950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.
    Wolters LM; van Nunen AB; Honkoop P; Vossen AC; Niesters HG; Zondervan PE; de Man RA
    J Viral Hepat; 2000 Nov; 7(6):428-34. PubMed ID: 11115054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine for chronic delta hepatitis.
    Lau DT; Doo E; Park Y; Kleiner DE; Schmid P; Kuhns MC; Hoofnagle JH
    Hepatology; 1999 Aug; 30(2):546-9. PubMed ID: 10421666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical meaning of the emergence of viral breakthrough during lamivudine treatment in patients with hepatitis B virus related chronic liver disease].
    Park CB; Lim HJ; Yun BC; Lee SU; Han BH
    Korean J Hepatol; 2004 Jun; 10(2):108-16. PubMed ID: 15218344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
    Flink HJ; Sprengers D; Hansen BE; van Zonneveld M; de Man RA; Schalm SW; Janssen HL;
    Gut; 2005 Nov; 54(11):1604-9. PubMed ID: 15923670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
    Niro GA; Ciancio A; Tillman HL; Lagget M; Olivero A; Perri F; Fontana R; Little N; Campbell F; Smedile A; Manns MP; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2005 Aug; 22(3):227-32. PubMed ID: 16091060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
    Babiker ZOE; Hogan C; Ustianowski A; Wilkins E
    J Med Microbiol; 2012 Dec; 61(Pt 12):1780-1783. PubMed ID: 22956751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.
    Kim JH; Yu SK; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Lee CH; Byun KS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1220-5. PubMed ID: 17532786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.
    Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M
    J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B virus genotypes and the response to lamivudine therapy].
    Zalewska M; Domagała M; Simon K; Gładysz A
    Pol Arch Med Wewn; 2005 Dec; 114(6):1190-9. PubMed ID: 16789488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.
    Su CW; Wu CY; Hung HH; Wu CH; Sheen IJ; Wu JC
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1849-58. PubMed ID: 23730852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection.
    Govindarajan S; Cassidy WM; Valinluck B; Redeker AG
    Prog Clin Biol Res; 1991; 364():207-10. PubMed ID: 2020697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine for chronic hepatitis B and HIV co-infection.
    Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
    AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.